Home
Browse
Search
Latest additions
Policies
FAQ
About Open Access
Browse by Author
Browse by Year
Browsing publications by
Dr Stuart Bennett
Newcastle Authors
Title
Year
Professor Simon Pearce
Dr Anna Mitchell
Dr Stuart Bennett
Professor John Isaacs
Dr Bijayeswar Vaidya
et al.
Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease
2012
Professor Mark Walker
Dr Muthu Jayapaul
Dr Stuart Bennett
Erratum: Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (Diabetologia http://dx.doi.org/10.1007/s00125-005-0004-7)
2006
Professor Mark Walker
Dr Muthu Jayapaul
Dr Stuart Bennett
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (vol 49, pg 1131, 2006)
2006
Dr Ibrahim Ibrahim
Dr Ee Lim
Dr Salman Razvi
Professor Simon Pearce
Dr Stuart Bennett
et al.
Langerhans cell histiocytosis: management dilemma for the adult endocrinologist
2006
Professor Mark Walker
Dr Muthu Jayapaul
Dr Stuart Bennett
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects
2005
Dr Stuart Bennett
Professor Mark Walker
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: Does it really work? If yes, is it a novelty?
2005
Dr Stuart Bennett
Professor Mark Walker
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance
2004
Professor Louise Parker
Dr Douglas Lamont
Professor Nigel Unwin
Dr Mark Pearce
Dr Stuart Bennett
et al.
A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years
2003
Professor Louise Parker
Dr Douglas Lamont
Professor Nigel Unwin
Dr Mark Pearce
Dr Stuart Bennett
et al.
A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years.[Erratum appears in Diabet Med. 2003 Sep;20(9):781]
2003
Dr Stuart Bennett
Dr Richard Quinton
Congenital hypopituitarism presenting as adult-onset hypogonadotrophic hypogonadism
2002
1
2